Tile overview image

Webcast

1.00 CME Credit

What Primary Care Clinicians Need to Know About Alzheimer’s Disease: Early Diagnosis, Patient-Specific Management, and Care CollaborationAn Interactive Learning Experience From ArcheMedX
This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

What do primary care providers (physicians, nurse practitioners, and physician assistants) need to know about caring for patients with Alzheimer’s disease (AD)? Primary care providers (PCPs) are well positioned to spot the earliest signs of cognitive decline — and patients are more likely to discuss sensitive topics, such as cognitive concerns, with a provider they know and trust.

This engaging activity will provide you with the latest information regarding the role of PCPs in early diagnosis of AD, approaches to address racial and ethnic barriers to dementia-related care, and strategies to encourage collaboration among PCPs and AD specialists. Patient-specific management considerations, including the role of recently approved and emerging disease-modifying therapies, will also be addressed. Following completion of this 60-minute educational activity, you will be better equipped to optimize care for your patients with AD.

Begin

CME Information

1.00 AMA PRA Category 1 Credits™, 1.00 ABIM MOC or 1.00 AANP, including 0.33 AANP Pharm

Release Date: 8/31/2022

Expiration Date: 8/30/2023

Learning Objectives

  • Implement equitable strategies to promote early and accurate diagnosis of AD in the primary care setting
  • Describe strategies for primary care clinicians and neurologists to form partnerships to provide optimal care for all patients with AD
  • Develop evidence-based, patient-specific treatment approaches, which may include disease-modifying therapies, for patients with AD
     

Faculty

Richard S. Isaacson, MD

Director, Center for Brain Health
Director, Alzheimer’s Prevention Clinic
Charles E. Schmidt College of Medicine
Florida Atlantic University
Boca Raton, FL
Adjunct Associate Professor of Neurology 
Department of Neurology
Weill Cornell Medicine/New York-Presbyterian
New York City, NY

Learn More

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor
UC Irvine Department of Family Medicine
Assistant Dean for Culture and Community Education
Executive Director, UC Irvine Program in Medical Education for the Latino Community
UC Irvine School of Medicine
Irvine, CA

Learn More

Disclosures

The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute.

Richard S. Isaacson, MD: Consultant for Acadia Pharmaceuticals, Inc., Avanir Pharmaceuticals, Inc., Biogen, Genentech, Lilly, and Novo Nordisk.

Charles Vega, MD: No relevant financial relationships disclosed.

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.

CME Information

AMA PRA Category 1 Credits

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Pri-Med Institute and Spire Learning. Pri-Med Institute is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Pri-Med Institute designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AANP

Accreditation Statement

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of Pri-Med Institute and Spire Learning. Pri-Med Institute is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider Number 040308.

Designation Statement

This activity is approved for 1.00 contact hours of continuing education, which includes 0.33 hours of pharmacology.

MOC Credit Information

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

Supporters and Partners

Commercial Supporter

Eisai

Education Partner

Spire Learning

Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients. Data, indications, and guidelines presented in this activity are current as of the activity release date and they are subject to change as new information is published.

Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.

Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. Pri-Med Institute is the accredited provider for this activity.

Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation.

Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.

Questions? If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.

What Primary Care Clinicians Need to Know About Alzheimer’s Disease: Early Diagnosis, Patient-Specific Management, and Care Collaboration

Begin